Table 1 Clinical characteristics of study patients.
From: Neuropsychiatric symptoms and seizure related with serum cytokine in epilepsy patients
Subject characteristics | Total (n = 134) |
|---|---|
Age—yr | 31.0 (23.0–48.8) |
Female sex—no. (%) | 59 (44.0) |
Seizure during video-EEG monitoring—no. (%) | 32 (23.9) |
Seizure frequency (/month) | 1.0 (0.2–3.5) |
Period from the last seizure (days) | 22.5 (6.0–58.5) |
Epilepsy syndrome type—no. (%) | |
TLE | 74 (55.2) |
FLE | 12 (9.0) |
PLE | 8 (6.0) |
OLE | 3 (2.2) |
GE | 27 (20.1) |
Multifocal/unknown | 10 (7.5) |
Epilepsy etiology—no. (%) | |
Idiopathic | 91 (67.9) |
Structural | 39 (29.1) |
Genetic | 1 (0.7) |
Post infectious | 3 (2.2) |
Disease onset—yr | 20 (14.0–40.5) |
Disease duration—yr | 6 (1–15) |
Number of AEDs | 1 (1.0–2.0) |
Baseline cytokine (n = 132) | |
IL-1β (pg/mL) | 4.1 (3.4–4.6) |
IL-2 (pg/mL) | 34.6 (14.4–248.5) |
IL-6 (pg/mL) | 6.2 (5.0–8.5) |
IFN-γ (pg/mL) | 18.5 (14.8–23.8) |
CCL2 (pg/mL) | 88.9 (72.9–118.0) |
CCL5 (pg/mL) | 323.7 (198.5–447.3) |
